Indication

Hypophosphatemia

Hypophosphatemia is an electrolyte disorder characterized by abnormally low levels of inorganic phosphate in the blood, typically defined in adults as a serum phosphate concentration below 2.5 mg/dL. Read more about Hypophosphatemia

64 drugs 41 manufacturers

Advertisement

Drugs that treat it

Common Hypophosphatemia therapies.

Showing 19–27 of 64 drugs

CALCITRIOL

VITAMIN D·HYPOPARATHYROIDISM·+5
ROXANE/WEST-WAR

CALCITRIOL

VITAMIN D·HYPOPARATHYROIDISM·+5
ROXANE/WEST-WAR

CALCITRIOL

VITAMIN D·HYPOPARATHYROIDISM·+5
APP/FRESENIUS K
Filter & compare in the drug finder →Opens the drug finder with Hypophosphatemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypophosphatemia.

Hypophosphatemia is an electrolyte disorder characterized by abnormally low levels of inorganic phosphate in the blood, typically defined in adults as a serum phosphate concentration below 2.5 mg/dL.

It affects multiple organ systems—most notably the musculoskeletal, neurological, cardiac, and respiratory systems—often presenting in hospitalized individuals, critically ill patients, or those with malnutrition, refeeding syndrome, or renal wasting disorders.

Pathophysiologically, it arises from reduced intestinal absorption, increased urinary excretion, or rapid transcellular shifts of phosphate into cells.

Because phosphate is essential for cellular adenosine triphosphate synthesis and cell membrane integrity, deficiency can precipitate muscle weakness, respiratory depression, encephalopathy, rhabdomyolysis, and impaired bone mineralization.

Personalize your experience

Follow Hypophosphatemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it